The INVICTUS Rheumatic Heart Disease Research Program: Rationale, Design and Baseline Characteristics of a Randomized Trial of Rivaroxaban Compared to Vitamin K Antagonists in Rheumatic Valvular Disease and Atrial FibrillationGanesan Karthikeyan,Stuart J. Connolly,Mpiko Ntsekhe,Alexander Benz,Sumathy Rangarajan,Gayle Lewis, Yan Yun,Sanjib Kumar Sharma, Fathi Maldady, Alaa Eldin Elghamrawy,Khawar Kazmi, Tantchou T. J. Cabral,Hu Dayi, Ma Changsheng,Bernard M. Gitura,Alvaro Avezum,Liesl Zuhlke,Peter Lwabi,Abraham Haileamlak,Okechukwu Ogah,Pilly Chillo,Maria Paniagua,Ahmed ElSayed,Antonio Dans,Lillian Gondwe-Chunda,Onkabetse Julia Molefe-Baikai,Jesus A. Gonzalez-Hermosillo,James Hakim,Albertino Damasceno,Emmanuel R. Kamanzi,John Musuku,Kairat Davletov,Katherine Connolly,Bongani M. Mayosi,Salim YusufAMERICAN HEART JOURNAL（2020）引用 52|浏览53关键词RivaroxabanAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
